Impact of Community-Based Biofeedback Program on Drug Use and Mental Health Among People Experiencing Homelessness
HRV-BF
1 other identifier
interventional
40
1 country
3
Brief Summary
The purpose of this randomized controlled trial was to compare the effectiveness of an HRV-BF intervention versus a health promotion active control intervention focused on improving mental health symptoms among people experiencing homelessness (PEH), who were residing in Skid Row, Los Angeles. In total, 40 PEH were randomized to either the HRV-BF or an active health promotion control group, and received 8 weekly, 30-minute sessions over a two month period, delivered by a nurse-led community health worker team. Dependent variables of HRV, mental health, anxiety, depression and PTSD were measured at baseline, the 8-week session, and/or 2-month follow up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2022
Shorter than P25 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 22, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 21, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 21, 2022
CompletedFirst Submitted
Initial submission to the registry
May 12, 2023
CompletedFirst Posted
Study publicly available on registry
June 9, 2023
CompletedJune 9, 2023
June 1, 2023
4 months
May 12, 2023
June 8, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Heart Rate Variability
Commercially available, medical grade photodetector (photoplethysmography or PPG) sensor and accompanying HRV-BF software application (EmWave Pro Plus, HeartMath) will be used to collect interbeat interval data to produce standard measures of HRV including time-domain measures of SDNN (standard deviation of N-to-N intervals) and RMSSD (Root mean square of successive differences between normal heart beats). Both SDNN and RMSSD are measured in milliseconds (ms). RMSSD is most reflective of vagal tone and is our primary outcome measure.
Change Assessed during the resting 5-minute period at week 1 and week 8 sessions
Secondary Outcomes (7)
Mental Health Status
Baseline and 8 weeks
Anxiety Symptoms
Baseline and 8 weeks
Depression Symptoms
Baseline and 8 weeks
Post Traumatic Stress Disorder (PTSD)
Baseline and 8 weeks
Drug and Alcohol Use
Baseline and 8 weeks
- +2 more secondary outcomes
Other Outcomes (1)
Social Support
Baseline and 8 weeks
Study Arms (2)
Heart Rate Variability-Biofeedback (HRV-BF)
EXPERIMENTALHeart Rate Variability-Biofeedback (HRV-BF) is a process by which physiological markers such as heart rate, respiration, and HRV are measured and "fed" back to the person on a computer screen. Guided paced slowed breathing, a skill taught in HRV-BF, maximizes the natural acceleration of heart rate with inspiration and deceleration with expiration and produces a rhythmic stimulation of the vagus nerve, providing the basis for the overall increase in parasympathetic/vagal tone over time if practiced regularly.
Health Promotion (HP)
ACTIVE COMPARATORThe Health Promotion (HP) active control group was originally developed utilizing community-based participatory research elements, including the establishment of a Community Advisory Board (CAB), with community stakeholders, social service providers and academicians and a manualized program was developed for the HP program. The 8-week program focused on the most common physical chronic diseases PEH experience, and included discussions of hypertension, diabetes, heart disease and arthritis; total over eight weeks, along with full discussion and referrals provided based on needs expressed by PEH.
Interventions
The HRV-BF was delivered over 30 minutes once weekly for 8 weeks by our nurse-led Community Health Worker (RN/CHW) team trained to deliver scripted material created by a trained biofeedback practitioner on our study team. The weekly sessions included the use of a tablet device to share a 10-minute video which teaches the basic techniques and breathing practices of HRV-BF and guiding the participant through a 20-minute practice, using the techniques while watching their heart rate data in real time using an HRV-BF device, the EmWave Pro (HeartMath). Participants were also asked to complete daily practices on their own, without the HRV-BF device, for 10 minutes, twice a day, to reinforce topics and skills taught in videos. Practices logged by the participant were collected weekly by the CHW and referral to resources were provided.
The HP active control group was delivered over 30 minutes, once weekly for 8 weeks by our nurse-led Community Health Worker team, trained to deliver scripted materialized content created. In the HP program, PEH were educated on common physical chronic diseases PEH experience, including hypertension, diabetes, heart disease and arthritis, along with referrals provided based on needs expressed by PEH.
Eligibility Criteria
You may qualify if:
- age 18 and older
- self-reported as residing in a homeless living condition during the previous night
- self-reported having used illicit substances or alcohol during the past year
You may not qualify if:
- Persons who:
- exclusively spoke languages other than English or Spanish
- were unable to understand informed consent
- had cardiac deficiency, arrhythmias or pacemakers or who took medications affecting autonomic function.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Amity Foundation, Los Angeles
Los Angeles, California, 90007, United States
Downtown Women Center, Los Angeles
Los Angeles, California, 90013, United States
Los Angeles Christian Health Centers (LACHC)
Los Angeles, California, 90013, United States
Related Publications (17)
Berwick DM, Murphy JM, Goldman PA, Ware JE Jr, Barsky AJ, Weinstein MC. Performance of a five-item mental health screening test. Med Care. 1991 Feb;29(2):169-76. doi: 10.1097/00005650-199102000-00008.
PMID: 1994148BACKGROUNDBlackburn L, Owens GP. The effect of self efficacy and meaning in life on posttraumatic stress disorder and depression severity among veterans. J Clin Psychol. 2015 Mar;71(3):219-28. doi: 10.1002/jclp.22133. Epub 2014 Sep 30.
PMID: 25270887BACKGROUNDForbes D, Creamer M, Biddle D. The validity of the PTSD checklist as a measure of symptomatic change in combat-related PTSD. Behav Res Ther. 2001 Aug;39(8):977-86. doi: 10.1016/s0005-7967(00)00084-x.
PMID: 11480838BACKGROUNDKroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x.
PMID: 11556941BACKGROUNDLaborde S, Mosley E, Thayer JF. Heart Rate Variability and Cardiac Vagal Tone in Psychophysiological Research - Recommendations for Experiment Planning, Data Analysis, and Data Reporting. Front Psychol. 2017 Feb 20;8:213. doi: 10.3389/fpsyg.2017.00213. eCollection 2017.
PMID: 28265249BACKGROUNDLeake B, Nyamathi A, Gelberg L. Reliability, validity, and composition of a subset of the Centers for Disease Control and Prevention acquired immunodeficiency syndrome knowledge questionnaire in a sample of homeless and impoverished adults. Med Care. 1997 Aug;35(8):747-55. doi: 10.1097/00005650-199708000-00001.
PMID: 9268248BACKGROUNDLehrer P, Kaur K, Sharma A, Shah K, Huseby R, Bhavsar J, Sgobba P, Zhang Y. Heart Rate Variability Biofeedback Improves Emotional and Physical Health and Performance: A Systematic Review and Meta Analysis. Appl Psychophysiol Biofeedback. 2020 Sep;45(3):109-129. doi: 10.1007/s10484-020-09466-z.
PMID: 32385728BACKGROUNDMcDonald SD, Calhoun PS. The diagnostic accuracy of the PTSD checklist: a critical review. Clin Psychol Rev. 2010 Dec;30(8):976-87. doi: 10.1016/j.cpr.2010.06.012. Epub 2010 Jul 6.
PMID: 20705376BACKGROUNDNyamathi A. Comprehensive health seeking and coping paradigm. J Adv Nurs. 1989 Apr;14(4):281-90. doi: 10.1111/j.1365-2648.1989.tb03415.x.
PMID: 2661620BACKGROUNDPorges SW. The polyvagal perspective. Biol Psychol. 2007 Feb;74(2):116-43. doi: 10.1016/j.biopsycho.2006.06.009. Epub 2006 Oct 16.
PMID: 17049418BACKGROUNDSalem BE, Ma-Pham J. Understanding Health Needs and Perspectives of Middle-Aged and Older Women Experiencing Homelessness. Public Health Nurs. 2015 Nov-Dec;32(6):634-44. doi: 10.1111/phn.12195. Epub 2015 Mar 31.
PMID: 25832775BACKGROUNDSamuelson KW, Bartel A, Valadez R, Jordan JT. PTSD symptoms and perception of cognitive problems: The roles of posttraumatic cognitions and trauma coping self-efficacy. Psychol Trauma. 2017 Sep;9(5):537-544. doi: 10.1037/tra0000210. Epub 2016 Oct 13.
PMID: 27736138BACKGROUNDSangha O, Stucki G, Liang MH, Fossel AH, Katz JN. The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum. 2003 Apr 15;49(2):156-63. doi: 10.1002/art.10993.
PMID: 12687505BACKGROUNDSherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991;32(6):705-14. doi: 10.1016/0277-9536(91)90150-b.
PMID: 2035047BACKGROUNDSpitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7. doi: 10.1001/archinte.166.10.1092.
PMID: 16717171BACKGROUNDWilkins KC, Lang AJ, Norman SB. Synthesis of the psychometric properties of the PTSD checklist (PCL) military, civilian, and specific versions. Depress Anxiety. 2011 Jul;28(7):596-606. doi: 10.1002/da.20837. Epub 2011 Jun 16.
PMID: 21681864BACKGROUNDWingood GM, DiClemente RJ. The ADAPT-ITT model: a novel method of adapting evidence-based HIV Interventions. J Acquir Immune Defic Syndr. 2008 Mar 1;47 Suppl 1:S40-6. doi: 10.1097/QAI.0b013e3181605df1.
PMID: 18301133BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Distinguished Professor
Study Record Dates
First Submitted
May 12, 2023
First Posted
June 9, 2023
Study Start
February 22, 2022
Primary Completion
June 21, 2022
Study Completion
October 21, 2022
Last Updated
June 9, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will not share